Navigation Links
Powerful Anti-breast-cancer Pill on the Anvil

The US Food and Drug Administration (FDA) has granted marketing approval to pharmaceutical giant GlaxoSmithKline for its breast cancer// pill Tykerb.

It has been claimed that Tykerb is far more potent in combating advanced stages of breast cancer than the drugs currently available for the purpose.

Breast cancer is the second leading cause of cancer deaths in women worldwide. According to statistics, about a million new cases are expected to occur this year itself. Analysts reckon Tykerb could be generating 1 billion US dollars in sales by 2010. By then, it is likely to be approved for wider breast cancer indications, and other cancer types such as head and neck and renal. Further trials are underway.

Tykerb seeks to specifically target cancer-causing proteins and more effective than other new generation drugs of the genre like Herceptin.

Experts note that Herceptin has been found to have a lot of limitations, some cancers become resistant to it even. Also while Herceptin is injectible Tykerb is a pill.

Even more important, it has no side-effects, of the cardiovascular type seen in other drugs, according to Dr.K.Geeta, a surgeon attached to the Rajiv Gandhi Cancer Institute, New Delhi.

However, industry sources warn that it would be prohibitively expensive and would require governmental intervention to make it affordable for the average Indian.
'"/>




Page: 1

Related medicine news :

1. Direct To Home: Television Provides Powerful Fillip to Smoking Cessation Campaigns.
2. Figment of Imagination? A Powerful US Economy Gives Rise to Fatal Heart Attacks
3. AIDS – A Powerful Mankille
4. Powerful Synergy: Botswana and Clinton foundation To Sign MOU
5. A New Study Finds Chocolate Milk Powerful Than Sports Drinks
6. Scientists Come Up With A Powerful Weapon To Fight Drug Resistant Bacteria
7. Powerful New IVF Treatment Promises Better Results
8. MEG Scanners Are Mega Powerful
9. Learning Words by Inference More Powerful for Toddlers
10. Crusade Against Cancer: Collaborations On The Anvil
11. New Drug For Oral Cancer Detection On The Anvil
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:9/22/2017)... ... September 22, 2017 , ... Ecocor , ... Richard Pedranti Architect (RPA), a full-service architecture firm focusing on sustainable design, ... Line of Model Homes . Independently, Ecocor and RPA have extensive experience with ...
(Date:9/22/2017)... (PRWEB) , ... September 22, 2017 , ... ... inaugural SABRE Safe Is Smart Scholarship Sweepstakes.,  , Molli C., a graduate student ... MS in Educational Leadership and Administration at St. Thomas University in Miami, Florida, ...
(Date:9/22/2017)... ... September 22, 2017 , ... “Cursed with a Curse: ... tithe, and the freedom experienced when breaking free from this misconception. “Cursed with ... M. Harrison. , Published by Christian Faith Publishing, Lysa M. Harrison’s new book ...
(Date:9/22/2017)... ... , ... "Success Files," a short- and long-form documentary style ... disease estimated to affect the lives of more than 5 million Americans living ... leading voice in the fight for cure and research into the disease, its ...
(Date:9/22/2017)... ... 2017 , ... “Letters From Home”: a moving compilation of letters that ... God. “Letters From Home” is the creation of published author, John Allred, a passionate ... Jerry Savelle Ministries International, who has traveled and ministered on four continents. , “It ...
Breaking Medicine News(10 mins):
(Date:9/7/2017)... IRVING, Texas , Sept. 7, 2017 /PRNewswire/ ... molecular science focused on fulfilling the promise of ... that further validate the benefits of its molecular ... Each study utilized comprehensive genomic profiling plus (CGP+) ... each individual patient,s tumor on a molecular level, ...
(Date:9/6/2017)... ANTONIO , Sept. 6, 2017  Robert G. ... a Pinnacle Professional Member in recognition of his contributions ... Szewc serves as a Nephrologist at the practice of ... emergency medicine, kidney care and hypertension solutions. He has ... 20 years of career experience, as well as expertise ...
(Date:9/6/2017)... Eli Lilly and Company (NYSE: LLY ) ... and lasmiditan, two investigational treatments for migraine, at the ... place Sept. 7-10 in Vancouver . ... from an open-label study evaluating the safety and effectiveness ... mg) for the prevention of migraine. Galcanezumab is a ...
Breaking Medicine Technology: